Nuclear IGF-1R predicts chemotherapy and targeted therapy resistance in metastatic colorectal cancer
Jordi Codony‐Servat(Breast Cancer Research Foundation), Joan Maurel(Breast Cancer Research Foundation)
Cited by 76
Related Papers
Differential cellular and molecular effects of bortezomib, a proteasome inhibitor, in human breast cancer cells
|Molecular Cancer Therapeutics|2006|107
Hsp90 inhibitors enhance the antitumoral effect of osimertinib in parental and osimertinib-resistant non-small cell lung cancer cell lines
|Translational Lung Cancer Research|2019|17